XKH002 Injection

XKH002 · Zhejiang Kanova Biopharmaceutical Co., LTD

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XKH002 Injection, covering 2024-10-10 to 2024-10-10. Get the full timeline:

Most recent: Clinical Trial Update: Phase I of XKH002 Injection in Patients [Phase 1]